期刊文献+

人工肝支持系统治疗时的并发症及其防治 被引量:1

Prevention and Treatment of Complications Caused by ALSS
下载PDF
导出
摘要 目的:探讨人工肝支持系统治疗各型重症肝炎患者的并发症及其防治方法。方法:统计分析人工肝支持系统治疗重症肝炎115次共23人次时并发症的发生情况。结果:治疗过程中共发生皮疹18人次(7.41%),血压一过性下降10人次(4.11%),血管路部分凝血6人次(2.47%),下肢抽搐8人次(3.29%),无过敏性休克病例发生,无发热、畏寒、寒战、出血病例发生,所有并发症经及时处理后均治愈,不影响治疗,结论:人工肝支持系统治疗重量型肝炎可发生多种并发症,但发生率很低,采取相应措施后可避免,从而提高重型肝炎的临床治愈好转率,ALSS治疗是很较安全且有效的方法。 Objective:To investigate the methods of Prevention and treatment of complications caused by using Artificial Liver Suspension System (ALSS) to treat severe hepatitis patients. Methods: Analyse the 115 severe hepatitis patients' complications caused by using ALSS. Results:In the duratio of the treatment with ALSS,7.41% patients show the symptom of rash,4.11% patients' blood pressure decrease,3.29% patients show the symptom of convulsions ,2.47% patients show partly intravascular coagulation without the symptom of anaphylactic shock, fever, rigour and bleeding. The complications disappear when treat the patients timely. Conclusion:Though some complications take place in the duration of the treatment with ALSS ,or be corrected with close observation and timely effective measurements ,all complicatins will be avoided. So ALSS can increase the rate of improvement and even the rate of clinical cure of severe hepatitis patients.
机构地区 解放军第
出处 《透析与人工器官》 2006年第1期42-45,共4页 Chinese Journal of Dialysis and Artificial Organs
关键词 人工肝支持系统(ALSS) 重型肝炎 并发症 Artificial liver suspension system(ALSS) Severe hepatitis Complications
  • 相关文献

参考文献6

二级参考文献7

  • 1田丁 陈锋 等.HLA与非溶血性输血反应[J].中华内科杂志,1988,27:88-90.
  • 2Kajitani M,Aguinaga M,Johnson CE,et al. Use of plasma exchange and heparin during cardiopulmonary bypass for a patient with heparin induced thrombocytopenia:a case report[J]. J Card Surg,2001,16(4):313-318.
  • 3Kakkar VV ,Gebska M ,Kadziola Z,et al. Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis[J]. Thromb Haemost, 2003,89(4):674-680.
  • 4Hafner G,Klingle R,Wandel B,et al. Laboratory control of minimal heparinization during hemodialysis in patients with a risk of hemorrhage[J]. Blood Coagul Fibrilysis, 1994,5:211-226.
  • 5Lai KN ,Wang AY,Ho K,et al. Use of low-dose low molecular weight heparin in hemodialysis [J]. Am J Kidney Dis, 1996,28(5):721-726.
  • 6孟运运,许家璋,杨志国,鞠九龙.肝炎患者庚型肝炎病毒感染状况调查及血清学分析[J].中国现代医学杂志,2000,10(1):66-66. 被引量:3
  • 7龙邕泉,申卫东,黄金环.63例发热性输血反应患者白细胞抗体的检测及分析[J].中国输血杂志,1992,5(3):119-121. 被引量:8

共引文献14111

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部